Thanh H. Dellinger

1.9k total citations
77 papers, 1.3k citations indexed

About

Thanh H. Dellinger is a scholar working on Reproductive Medicine, Oncology and Surgery. According to data from OpenAlex, Thanh H. Dellinger has authored 77 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Reproductive Medicine, 26 papers in Oncology and 24 papers in Surgery. Recurrent topics in Thanh H. Dellinger's work include Ovarian cancer diagnosis and treatment (31 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Intraperitoneal and Appendiceal Malignancies (18 papers). Thanh H. Dellinger is often cited by papers focused on Ovarian cancer diagnosis and treatment (31 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Intraperitoneal and Appendiceal Malignancies (18 papers). Thanh H. Dellinger collaborates with scholars based in United States, Germany and Australia. Thanh H. Dellinger's co-authors include Ernest Han, Wei Wen, Mark T. Wakabayashi, Bradley J. Monk, Carlotta A. Glackin, Cai M. Roberts, John H. Yim, Richard Jove, Jun Wu and James Finlay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Thanh H. Dellinger

72 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thanh H. Dellinger United States 22 542 424 237 233 203 77 1.3k
Xiugui Sheng China 23 513 0.9× 304 0.7× 233 1.0× 344 1.5× 223 1.1× 74 1.4k
Xingsheng Yang China 27 800 1.5× 409 1.0× 334 1.4× 412 1.8× 202 1.0× 95 1.8k
Xiaoyan Xin China 25 998 1.8× 426 1.0× 234 1.0× 365 1.6× 139 0.7× 115 1.9k
Lorna Rodríguez-Rodríguez United States 21 546 1.0× 422 1.0× 352 1.5× 276 1.2× 54 0.3× 38 1.3k
Ying‐Cheng Chiang Taiwan 23 529 1.0× 552 1.3× 591 2.5× 222 1.0× 195 1.0× 85 1.8k
Haoran Li China 14 491 0.9× 336 0.8× 91 0.4× 345 1.5× 169 0.8× 81 1.1k
Naoyo Nishida Japan 12 837 1.5× 401 0.9× 94 0.4× 366 1.6× 87 0.4× 27 1.5k
Shulan Zhang China 25 851 1.6× 332 0.8× 185 0.8× 358 1.5× 131 0.6× 96 1.7k
Lu Xu China 18 577 1.1× 156 0.4× 92 0.4× 336 1.4× 141 0.7× 49 1.2k
Lingya Pan China 22 494 0.9× 228 0.5× 590 2.5× 236 1.0× 193 1.0× 108 1.4k

Countries citing papers authored by Thanh H. Dellinger

Since Specialization
Citations

This map shows the geographic impact of Thanh H. Dellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thanh H. Dellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thanh H. Dellinger more than expected).

Fields of papers citing papers by Thanh H. Dellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thanh H. Dellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thanh H. Dellinger. The network helps show where Thanh H. Dellinger may publish in the future.

Co-authorship network of co-authors of Thanh H. Dellinger

This figure shows the co-authorship network connecting the top 25 collaborators of Thanh H. Dellinger. A scholar is included among the top collaborators of Thanh H. Dellinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thanh H. Dellinger. Thanh H. Dellinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brennan, Donal J., Michela Cinquini, Aditi Bhatt, et al.. (2025). Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Epithelial Ovarian Cancer: A GRADE Approach for Evidence Evaluation and Recommendation. Journal of Surgical Oncology. 132(5). 885–894. 1 indexed citations
2.
Ruel, Nora, Richard L. Whelan, Marwan Fakih, et al.. (2024). Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial. Annals of Surgical Oncology. 31(12). 7998–8007. 1 indexed citations
3.
Wei, Christina, et al.. (2023). Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma. Journal of Clinical Medicine. 12(11). 3839–3839. 4 indexed citations
4.
Adamson, A. W., Yuan Chun Ding, Linda Steele, et al.. (2023). Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of Ovarian Research. 16(1). 141–141. 6 indexed citations
6.
Raoof, Mustafa, Gautam Malhotra, Michael P. O’Leary, et al.. (2021). PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial. Annals of Surgical Oncology. 29(1). 175–185. 13 indexed citations
7.
Stewart, Camille L., Mustafa Raoof, Yuman Fong, Thanh H. Dellinger, & Susanne G. Warner. (2021). Who is hurting? A prospective study of surgeon ergonomics. Surgical Endoscopy. 36(1). 292–299. 11 indexed citations
8.
Cristea, Mihaela, Paul Frankel, Timothy W. Synold, et al.. (2020). 863P A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in pts with selected FRα -positive solid tumours: Results in the endometrial cancer (EC) cohort. Annals of Oncology. 31. S639–S639. 1 indexed citations
9.
Haber, Tom, Soraya Aramburo, Pengpeng Cao, et al.. (2020). Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles. Proceedings of the National Academy of Sciences. 117(33). 19737–19745. 36 indexed citations
10.
Chung, Christopher, Mark T. Wakabayashi, Thanh H. Dellinger, et al.. (2020). Prolapse repair after anterior exenteration. International Urogynecology Journal. 32(4). 1037–1038.
11.
Hammad, Mohamed, Zheng Liu, Yuan Yuan, et al.. (2020). Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer Model. Molecular Therapy — Oncolytics. 18. 326–334. 21 indexed citations
12.
Cristea, Mihaela, Wenge Wang, Mark T. Wakabayashi, et al.. (2019). Highlights of the NCCN Oncology Research Program. Journal of the National Comprehensive Cancer Network. 17(1). xxxvii–xxxvii. 1 indexed citations
13.
Cristea, Mihaela, Wenge Wang, Mark T. Wakabayashi, et al.. (2019). Oncology Research Program. Journal of the National Comprehensive Cancer Network. 17(9). xxvi–xxvi. 1 indexed citations
14.
Li, Jie, Rachael Mooney, Soraya Aramburo, et al.. (2019). Silica Coated Paclitaxel Nanocrystals Enable Neural Stem Cell Loading For Treatment of Ovarian Cancer. Bioconjugate Chemistry. 30(5). 1415–1424. 8 indexed citations
15.
Cristea, Mihaela, Paul Frankel, Timothy W. Synold, et al.. (2019). A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Cancer Chemotherapy and Pharmacology. 83(3). 589–598. 25 indexed citations
16.
Dellinger, Thanh H., et al.. (2018). HIPEC treatment in advanced and recurrent ovarian cancer: a meta-analysis of observational studies. European Journal of Gynaecological Oncology. 39(3). 353–360.
17.
Cao, Pengpeng, Rachael Mooney, Revathiswari Tirughana, et al.. (2017). Intraperitoneal Administration of Neural Stem Cell–Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors. Bioconjugate Chemistry. 28(6). 1767–1776. 38 indexed citations
18.
Roberts, Cai M., Sophia Allaf Shahin, Wei Wen, et al.. (2016). Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 965–976. 67 indexed citations
19.
Dellinger, Thanh H., Amy Hakim, Stephen J. Lee, et al.. (2016). Surgical Management of Vulvar Cancer. Journal of the National Comprehensive Cancer Network. 15(1). 121–128. 39 indexed citations
20.
Eskander, Ramez N., Shamshad Ali, Thanh H. Dellinger, et al.. (2015). Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma. International Journal of Gynecological Cancer. 26(1). 125–132. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026